# Mingze Zhonghe

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mingze-zhonghe

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Website: www.mingzezhonghe.com
- Latest round: Series B (Jul 4, 2025)
- Investors on record: 2

## About

Based in Beijing, China, Mingze Zhonghe specializes in providing innovative technological solutions that enhance operational efficiency across various industries, including healthcare, finance, and logistics.Founded in 2014 in Beijing, China, Mingze Zhonghe focuses on delivering advanced technological solutions tailored to address operational challenges. The company has secured its first deal on July 4, 2025, highlighting its growth trajectory in the tech sector. Its founder has an extensive background in technology, although further details about previous ventures are not available.Mingze Zhonghe specializes in innovative technological solutions addressing operational challenges across various industries. Their core offerings include advanced software platforms that enhance data management, workflow efficiency, and analytical insights for sectors like healthcare, finance, and logistics. Over recent years, these products have gained traction in North America, Western Europe, and parts of Asia, serving a diverse clientele from small businesses to large enterprises, bolstering their commitment to high-quality services.The company's revenue model is subscription-based, allowing clients to access software solutions through various pricing tiers based on service levels and usage. This structure fosters long-term partnerships by enabling businesses to select plans tailored to their needs. Transactions are direct between the company and clients, ensuring streamlined onboarding and ongoing support. The primary product features a tiered pricing strategy accommodating both B2B and direct-to-consumer interactions, thus maintaining consistent revenue flow while expanding market presence.In July 2025, Mingze Zhonghe secured Series B funding from Huiyu Private Equity Fund Management (Huzhou) and Zhejiang Changxing Financial Holding Group. The capital raised will support the development of new products aimed at further enhancing operational efficiencies. The company plans to expand into new geographic markets, focusing on increased penetration in regions across Asia and Europe by early 2026. This strategic growth initiative aims to leverage recent funding to enhance product offerings and market reach.

## Funding rounds

- Series B, Jul 4, 2025 — Zhejiang Changxing Financial Holding Group, Huiyu Private Equity Fund Management (Huzhou)

## Investors

- Zhejiang Changxing Financial Holding Group — Series B
- Huiyu Private Equity Fund Management (Huzhou) (https://capitalatlas.ai/funds/huiyu-private-equity-fund-management-huzhou) — Series B